Information Library
Clinical and marketing materials - Cost control/reduction
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Early phase strategies
June 15, 2009
Web cast about Early Phase Strategies. -
QT Population Modeling and Simulation Case Study
June 15, 2009
The importance of determining the most strategic Phase I/IIa study conducted by leading specialists shouldn’t be understated. Gain insight into QT and Population Modeling & Simulation. -
Risk Assessment & Strategy
April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
Maneuvering a Drifting Project Back on Course
March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.
Page 1 of 1 (4 items)